Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Wolf

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Neurosurgery|July 1, 1984
Effects of a single large dose of methylprednisolone sodium succinate on experimental posttraumatic spinal cord ischemia. Dose-response and time-action analysisE D Hall, D L Wolf, J M Braughler
Journal of Clinical Pharmacology|February 1, 1993
Continuous intravenous dosing with ciprostene using a portable pump in ambulatory patientsD L Wolf, C M Metzler, M O Froeschke, et al.
Brain Research|December 1, 1987
Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injuryE D Hall, D L Wolf, J S Althaus, et al.
Protein Expression and Purification|December 1, 1992
Expression, purification, and characterization of inactive human coagulation factor Xa (Asn322Ala419)U Sinha, T E Hancock, P H Lin, et al.
Growth Factors (Chur, Switzerland)|January 1, 1994
The anion-binding exosite is critical for the high affinity binding of thrombin to the human thrombin receptorB D Blackhart, G Cuenco, T Toda, et al.
Blood|December 1, 1995
Procoagulant activity of reversibly acylated human factor XaD L Wolf, P H Lin, S Hollenbach, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The haemodynamic effects and pharmacokinetics of intravenous nicorandil in healthy volunteersD L Wolf, J J Ferry, A E Hearron, et al.
Thrombosis Research|August 15, 1994
Effect of gamma carboxylation on prothrombinase inhibitory activity of catalytically inactive factor XAU Sinha, T E Hancock, J J Nzerem, et al.
Growth Factors (Chur, Switzerland)|January 1, 1993
A novel monoclonal antibody dependent on domain 5 of the platelet-derived growth factor beta receptor inhibits ligand binding and receptor activationV Ramakrishnan, M A Escobedo, L J Fretto, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1994
Acute effects of increasing doses of nicorandil on renal function in manD L Wolf, G L Jungbluth, C M Metzler, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Neurosurgery|July 1, 1984
Effects of a single large dose of methylprednisolone sodium succinate on experimental posttraumatic spinal cord ischemia. Dose-response and time-action analysisE D Hall, D L Wolf, J M Braughler
Journal of Clinical Pharmacology|February 1, 1993
Continuous intravenous dosing with ciprostene using a portable pump in ambulatory patientsD L Wolf, C M Metzler, M O Froeschke, et al.
Brain Research|December 1, 1987
Beneficial effects of the kappa opioid receptor agonist U-50488H in experimental acute brain and spinal cord injuryE D Hall, D L Wolf, J S Althaus, et al.
Protein Expression and Purification|December 1, 1992
Expression, purification, and characterization of inactive human coagulation factor Xa (Asn322Ala419)U Sinha, T E Hancock, P H Lin, et al.
Growth Factors (Chur, Switzerland)|January 1, 1994
The anion-binding exosite is critical for the high affinity binding of thrombin to the human thrombin receptorB D Blackhart, G Cuenco, T Toda, et al.
Blood|December 1, 1995
Procoagulant activity of reversibly acylated human factor XaD L Wolf, P H Lin, S Hollenbach, et al.
European Journal of Clinical Pharmacology|January 1, 1993
The haemodynamic effects and pharmacokinetics of intravenous nicorandil in healthy volunteersD L Wolf, J J Ferry, A E Hearron, et al.
Thrombosis Research|August 15, 1994
Effect of gamma carboxylation on prothrombinase inhibitory activity of catalytically inactive factor XAU Sinha, T E Hancock, J J Nzerem, et al.
Growth Factors (Chur, Switzerland)|January 1, 1993
A novel monoclonal antibody dependent on domain 5 of the platelet-derived growth factor beta receptor inhibits ligand binding and receptor activationV Ramakrishnan, M A Escobedo, L J Fretto, et al.
International Journal of Clinical Pharmacology and Therapeutics|May 1, 1994
Acute effects of increasing doses of nicorandil on renal function in manD L Wolf, G L Jungbluth, C M Metzler, et al.
Pageof 3